MDWD (MediWound) Shiller PE Ratio: (As of Aug. 25, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MDWD MediWound Ltd MDWD
59 GF Score
Price $13.00
GF Value $10.67
Valuation Modestly Overvalued
! 7 Warning Signs
View Full Analysis

What is MediWound Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


MediWound  (NAS:MDWD) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


MediWound Shiller PE Ratio Related Terms


MediWound Shiller PE Ratio Historical Data

* Premium members only.

The historical data trend for MediWound's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MediWound Shiller PE Ratio Chart

MediWound Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

MediWound Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

MDWD vs WHWK, IMUX, IVVD: Shiller PE Ratio Comparison

For the Biotechnology subindustry, MediWound's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


MediWound Shiller PE Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, MediWound's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where MediWound's Shiller PE Ratio falls into.


MDWD
59GF Score
MediWound Ltd MDWD
Shiller PE Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

MediWound Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

MediWound's E10 for the quarter that ended in Jun. 2026 is calculated as:

For example, MediWound's adjusted earnings per share data for the three months ended in Jun. 2026 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=-0.77/333.9520*333.9520
=-0.770

Current CPI (Jun. 2026) = 333.9520.

MediWound Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201609 -1.820 241.428 -2.517
201612 -0.630 241.432 -0.871
201703 -1.400 243.801 -1.918
201706 -1.400 244.955 -1.909
201709 -3.430 246.819 -4.641
201712 -0.630 246.524 -0.853
201803 -1.190 249.554 -1.592
201806 -1.050 251.989 -1.392
201809 -0.770 252.439 -1.019
201812 2.730 251.233 3.629
201903 -1.050 254.202 -1.379
201906 3.290 256.143 4.289
201909 -0.070 256.759 -0.091
201912 -0.910 256.974 -1.183
202003 -0.630 258.115 -0.815
202006 -0.770 257.797 -0.997
202009 -0.491 260.280 -0.630
202012 -0.420 260.474 -0.538
202103 -0.700 264.877 -0.883
202106 -0.840 271.696 -1.032
202109 -0.840 274.310 -1.023
202112 -1.069 278.802 -1.280
202203 -0.870 287.504 -1.011
202206 -0.920 296.311 -1.037
202209 -0.880 296.808 -0.990
202212 -1.180 296.797 -1.328
202303 -0.440 301.836 -0.487
202306 0.100 305.109 0.109
202309 -0.240 307.789 -0.260
202312 -0.190 306.746 -0.207
202403 -1.050 312.332 -1.123
202406 -0.680 314.175 -0.723
202409 -0.980 315.301 -1.038
202412 -0.360 315.605 -0.381
202503 -0.070 319.799 -0.073
202506 -1.230 322.561 -1.273
202509 -0.240 324.800 -0.247
202512 -0.560 324.054 -0.577
202603 -0.230 330.213 -0.233
202606 -0.770 333.952 -0.770

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is MediWound (MDWD) Overvalued in 2026?

Based on GuruFocus' analysis, MediWound stock appears to be overvalued. The current stock price of $13.00 is trading 21.8% above its estimated GF Value™ of $10.67. GuruFocus considers MediWound to be Modestly Overvalued.

Key valuation signals for MDWD:

  • Shiller PE Ratio:
  • GF Value™: $10.67 vs. price of $13.00 (21.8% above fair value)
  • GF Score™: 59/100 with 7 warning signs

No single metric tells the full story. See the MDWD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


MediWound Business Description

Other Exchanges M8W:Germany
Address 42 Hayarkon Street, Yavne, ISR, 8122745
MediWound Ltd is an integrated biopharmaceutical company focused on developing, manufacturing, and commercializing novel therapeutic products to address unmet medical needs in the fields of severe burns, chronic and other hard-to-heal wounds, connective tissue disorders, and other indications. Its first biopharmaceutical product, NexoBrid, is an FDA-approved orphan biologic for eschar removal in severe burns that can replace surgical interventions and minimize associated costs and complications. Its other product candidates in different stages of the pipeline include EscharEx for debridement of chronic wounds and MW005 for the treatment of non-melanoma skin cancer. The company derives a majority of its revenue from the United States and the rest from the EU and other international markets.
59GF Score

Get the complete analysis for MDWD

Shiller PE Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$13.00
Price
$10.67
GF Value